| GP consultation |  | GP prescription |  | GP referral to other specialities |  | Palliative care needs recognised or not |  | |
---|---|---|---|---|---|---|---|---|---|
Palliative care | Yes | 1.29(1.27 to 1.31) | < 0.0001 | 1.16(1.14 to 1.18) | < 0.0001 | 1.21(1.17 to 1.25) | < 0.0001 |  |  |
Age at death (ref: < 50) | 50–59 | 0.96(0.93 to 1.00) | < 0.0001 | 1.08(1.00 to 1.15) | < 0.0001 | 1.10(0.99 to 1.22) | < 0.0001 | 0.98(0.93 to 1.03) | < 0.0001 |
60–69 | 0.94(0.91 to 0.97) |  | 1.20(1.13 to 1.28) |  | 1.15(1.04 to 1.27) |  | 0.88(0.84 to 0.93) |  | |
70–79 | 0.92(0.90 to 0.95) |  | 1.28(1.20 to 1.36) |  | 1.16(1.05 to 1.27) |  | 0.80(0.76 to 0.84) |  | |
80–89 | 0.86(0.83 to 0.89) |  | 1.37(1.28 to 1.46) |  | 1.14(1.03 to 1.25) |  | 0.67(0.64 to 0.71) |  | |
90+ | 0.79(0.76 to 0.82) | Â | 1.50(1.39 to 1.61) | Â | 0.99(0.88 to 1.10) | Â | 0.53(0.49 to 0.56) | Â | |
Gender (ref: female) | Male | 0.96(0.95 to 0.97) | < 0.0001 | 0.91(0.89 to 0.92) | < 0.0001 | 0.98(0.95 to 1.01) | 0.14 | 0.97(0.95 to 1.00) | 0.033 |
Cancer site (ref: Lung) | Colorectal | 0.99(0.97 to 1.01) | < 0.0001 | 1.07(1.04 to 1.10) | < 0.0001 | 1.05(1.00 to 1.10) | < 0.0001 | 0.76(0.73 to 0.79) | < 0.0001 |
Breast | 1.01(1.00 to 1.02) | Â | 0.97(0.94 to 0.99) | Â | 1.02(0.98 to 1.06) | Â | 0.90(0.87 to 0.92) | Â | |
Prostate | 1.20(1.18 to 1.22) | Â | 1.16(1.13 to 1.19) | Â | 1.24(1.18 to 1.30) | Â | 0.76(0.73 to 0.80) | Â | |
No. comorbid conditions (ref: 0) | 1 | 1.09(1.07 to 1.10) | < 0.0001 | 1.19(1.17 to 1.22) | < 0.0001 | 1.07(1.03 to 1.12) | < 0.0001 | 1.06(1.03 to 1.09) | < 0.0001 |
2 | 1.20(1.18 to 1.22) | Â | 1.45(1.41 to 1.49) | Â | 1.15(1.10 to 1.21) | Â | 1.07(1.04 to 1.11) | Â | |
3 | 1.17(1.14 to 1.19) | Â | 1.66(1.61 to 1.72) | Â | 1.24(1.18 to 1.31) | Â | 1.08(1.03 to 1.12) | Â | |
4+ | 1.25(1.23 to 1.28) | Â | 2.07(2.00 to 2.15) | Â | 1.38(1.29 to 1.48) | Â | 1.00(0.95 to 1.06) | Â | |
Time between diagnosis and death (ref: 120+) | 0–5 | 1.08(1.04 to 1.11) | < 0.0001 | 0.96(0.91 to 1.01) | < 0.0001 | 1.56(1.43 to 1.71) | < 0.0001 | 1.09(1.03 to 1.16) | < 0.0001 |
6–12 | 1.31(1.26 to 1.35) |  | 1.07(1.01 to 1.13) |  | 1.47(1.34 to 1.61) |  | 1.37(1.29 to 1.46) |  | |
13–36 | 1.09(1.06 to 1.13) |  | 1.04(1.00 to 1.10) |  | 0.95(0.87 to 1.04) |  | 1.39(1.31 to 1.48) |  | |
37–60 | 1.05(1.01 to 1.08) |  | 1.03(0.98 to 1.09) |  | 1.00(0.91 to 1.10) |  | 1.29(1.21 to 1.37) |  | |
61–120 | 1.01(0.97 to 1.04) |  | 0.97(0.92 to 1.02) |  | 1.02(0.93 to 1.11) |  | 1.16(1.09 to 1.24) |  | |
Year of death (ref: 2010–2014) | 2000–2004 | 0.64(0.61 to 0.67) | < 0.0001 | 0.77(0.75 to 0.80) | < 0.0001 | 1.07(0.94 to 1.22) | < 0.0001 | 0.50(0.47 to 0.54) | < 0.0001 |
2005–2009 | 0.85(0.82 to 0.87) |  | 0.90(0.87 to 0.92) |  | 0.89(0.84 to 0.94) |  | 0.84(0.81 to 0.87) |  | |
IMD (ref: most deprived) | Least depr | 1.02(0.99 to 1.04) | 0.24 | 0.86(0.83 to 0.89) | < 0.0001 | 1.07(0.99 to 1.14) | 0.10 | 1.09(1.04 to 1.13) | < 0.0001 |
2 | 1.02(1.00 to 1.04) | Â | 0.89(0.87 to 0.92) | Â | 1.06(0.99 to 1.13) | Â | 1.09(1.05 to 1.13) | Â | |
3 | 1.02(0.99 to 1.04) | Â | 0.91(0.88 to 0.94) | Â | 1.03(0.96 to 1.10) | Â | 1.03(0.99 to 1.07) | Â | |
4 | 1.00(0.98 to 1.02) | Â | 0.93(0.90 to 0.96) | Â | 1.01(0.95 to 1.07) | Â | 1.01(0.98 to 1.05) | Â |